Double-blinded, Randomized, Active control, Single center-designed, Phase I clinical trial to evaluate the safety and efficacy for improvement of Glabellar Lines of HG-102 compared to Botox® in subjects with moderate to severe Glabellar Lines
To compare the safety and efficacy of HG-102 with Botox® in the improvement of moderate to severe glabellar lines.